Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing Structures

Marita Meurer, Deborah A. O′Neil, Emma Lovie, Laura W. Simpson, Marcelo D. T. Torres, César de la Fuente‐Núñez, Alfredo M. Angeles‐Boza, Christin Kleinsorgen, Derry K. Mercer, Maren von Köckritz‐BlickwedeACS 2021 · DOI

Abstract

The need for optimized as well as standardized test systems of novel antimicrobial peptides (AMPs) was discussed by experts in the field at the International Meeting on Antimicrobial Peptides (IMAP) 2017 and the 2019 Gordon Research Conference (GRC) on Antimicrobial Peptides, and a survey related to this topic was circulated to participants to collate opinions. The survey included questions ranging from the relevance of susceptibility testing for understanding the mode of action of AMPs, to the importance of optimization and a degree of standardization of test methods and their clinical relevance. Based on the survey results, suggestions for future improvements in the research field are made.
BibTeX
@inproceedings{meurer2021antimicrobial,
  author = {Marita Meurer and Deborah A. O′Neil and Emma Lovie and Laura W. Simpson and Marcelo D. T. Torres and César de la Fuente‐Núñez and Alfredo M. Angeles‐Boza and Christin Kleinsorgen and Derry K. Mercer and Maren von Köckritz‐Blickwede},
  title = {{Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing Structures}},
  booktitle = {ACS},
  year = {2021},
  doi = {10.1021/acsinfecdis.1c00210},
}

Loading related content...

Figure